APA Citatie

Ren, C., Mai, Z., Jin, Y., He, M., Wang, Z., Luo, H., . . . Xu, R. (2020). Anti-PD-1 antibody SHR-1210 plus apatinib for metastatic colorectal cancer: A prospective, single-arm, open-label, phase II trial. Am J Cancer Res.

Chicago Style citaat

Ren, Chao, et al. "Anti-PD-1 Antibody SHR-1210 Plus Apatinib for Metastatic Colorectal Cancer: A Prospective, Single-arm, Open-label, Phase II Trial." Am J Cancer Res 2020.

MLA citatie

Ren, Chao, et al. "Anti-PD-1 Antibody SHR-1210 Plus Apatinib for Metastatic Colorectal Cancer: A Prospective, Single-arm, Open-label, Phase II Trial." Am J Cancer Res 2020.